Accordingly, CTHRC1 was identified as a novel oncogene aberrantly overexpressed in various malignant tumors, exhibiting associations with bone metastasis and unfavorable patient outcomes [68,69,70,71]. This evidence concerns the gene CTHRC1 and cancer.